Dr
Prince of Wales Hospital
Randwick, New South Wales, Australia
Dr Yeh Chen Lee (MBBS BMedSci MPhil[H1] FRACP) is a clinical investigator and medical oncologist with subspecialty expertise in gynaecological cancers and soft tissue sarcoma. Dr Lee is a Staff Specialist at the Prince of Wales – Royal Hospital for Women and Chris O'Brien Lifehouse; and a Research Fellow at the NHMRC Clinical Trials Centre (CTC), University of Sydney. Dr Lee completed a dual research fellowship at Peter MacCallum Cancer Centre (Melbourne, Australia; 2015-2016) and at Princess Margaret Cancer Centre (Toronto, Canada; 2016-2018) in Gynaecology and Drug Development.
Dr Lee’s research focus is to improve patient care, through advancing and translating knowledge in cancer genetics, drug development and supportive care. Dr Lee has completed a Master of Philosophy with first class honours (University of Melbourne) investigating ways to improve ovarian cancer care along the disease trajectory. Her research accomplishments included receipt of the GCIG Scholar Award (2019), CAHON Young Investigator Award (2018), Tannock Fellowship Award (2017) and Conquer Cancer Foundation of ASCO Merit Award (2016). Dr Lee’s research leadership includes as appointed chair of the NGOR (National Gynae-Oncology Registry) rare cancer group; member of the Research Advisory Committee and Ovarian Tumour Working Group for ANZGOG (Australia New Zealand Gynaecological Oncology Group); Scientific Advisory Committee member of the ANZSA (Australia New Zealand Sarcoma Association); and member of Gynaecological Cancer and Sarcoma Reference Committee for EviQ Cancer Treatment Online.
Dr Lee is highly active in clinical trials in cancers and has been involved in the conduct of >50 Phase I-III investigator-initiated and collaborative trials. Dr Lee is awarded more than $5 million of competitive grant funding since 2017. Dr Lee had 37 peer-reviewed publications (11 as first author) and written 5 educational materials and book chapters.
Disclosure information not submitted.
